| PERIOD ENDING | 10-Oct-09 | 20-Jun-09 | 28-Mar-09 | 14-Jun-03 | | Total Revenue | 1,938,173 | 1,714,722 | 1,596,590 | 1,216,822 | | Cost of Revenue | 1,761,371 | 1,492,606 | 1,392,719 | 1,048,760 | | | Gross Profit | 176,802 | 222,116 | 203,871 | 168,062 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 148,979 | 113,944 | 97,406 | 99,483 | | Non Recurring |
-
|
-
|
-
|
-
| | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 44,182 | 108,331 | 123,099 | 68,579 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (15,858) | (31,387) | 40,222 | (9,075) | | Earnings Before Interest And Taxes | 28,324 | 76,944 | 163,321 | 59,504 | | Interest Expense | 69,955 | 50,242 | 37,546 | 37,779 | | Income Before Tax | (41,631) | 26,702 | 125,775 | 21,725 | | Income Tax Expense | (32,715) | 8,963 | 8,048 | 3,824 | | Minority Interest | (830) | (977) | (897) |
-
| | | | Net Income From Continuing Ops | (53,436) | 20,857 | 102,287 | 17,901 | | | Non-recurring Events | | Discontinued Operations | 445 | 265 | 1,430 |
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (53,821) | 20,145 | 102,820 | 17,901 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($53,821) | $20,145 | $102,820 | $17,901 |
|
0.50% Nasdaq 
Income Statement
